{
    "nctId": "NCT00243607",
    "briefTitle": "Hydrotherapy Against Menopausal Symptoms in Breast Cancer Survivors",
    "officialTitle": "Prospective Randomized Feasibility Study on the Self Application of Hydrotherapy to Treat Menopausal Symptoms Caused by Breast Cancer Therapy",
    "overallStatus": "COMPLETED",
    "conditions": "Amenorrhea, Hot Flashes",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 45,
    "primaryOutcomeMeasure": "Menopausal complaints (MRS II)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer diagnosis\n* Menopausal complaints score \\> 14 (MRS II)\n* End of last chemotherapy or radiotherapy \\> 2 months\n* Expected stable disease for the next 6 months\n\nExclusion Criteria:\n\n* Regular intake of glucocorticoids\n* Regular practice of hydrotherapy before inclusion\n* Start or change of other treatments/changes of lifestyle in order to influence menopausal symptoms\n* Psychiatric disorders with possible influence on compliance and adherence to the protocol\n* Other severe or progressive diseases with influence on compliance and adherence to the protocol\n* Contraindications to hydrotherapy (severe heart failure, relevant dermatological diseases, Raynaud's Phenomenon \\[M. Raynaud\\], peripheral arterial occlusive disease Fontaine stage IIb \\[VK IIb\\] or more, acute thrombosis, or thrombophlebitis)",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}